Beta-Lactamase DataBase (BLDB): Structure and Function
Beta-Lactamase DataBase
Beta-Lactamase DataBase - Structure and Function Home Enzymes Structures Mutants Kinetics BLAST
Beta-Lactamase DataBase

Sequence alignment for the SDA-D-like beta-lactamase family

SDA-D-1
........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290.......300.......310.......320.....
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESGQQPGLGGCGTSAHGSADAHEKEFRALEKKFDAHPGVYAIDTRDGQEITHRADERFAYGSTFKALQAGAILAQVLRDGREVRRGAEADGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVAYSDNTAANLLFDQLGGRRGSTRVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGEKAALAPNDREQLNDWMSGSRTGDALIRAGVPKDWKVEDKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSHGDTQDAEPHDELVAEAGLVVADGLK
SDA-D-2 .................................AGSSPASAVR.......................TL.......A............................RKFSET.AKSGG...........................................R................PK.LNA...................................................................NA................A................................................AS.......  89.23 %
SDA-D-3 .................................AGSSPASAVR.......................TL.......A............................RKFSET.AKSGA...........................................R................PK.LNA................................................K..................NA................A...................................E............AS.......  88.62 %
A-SDA-D-like phylogenetic tree

Last updated: November 16, 2022.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu